Pharmaceutical development of a parenteral lyophilised formulation of the investigational anticancer agent ES-285.HCI

M.W.J. den Brok, B. Nuijen, D.M. Meijer, E. Millan, C. Manada, J.H. Beijnen

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	246-257
Number of pages	12
Journal	PDA Journal of Pharmaceutical Science and Technology
Volume	59
Issue number	4
Publication status	Published - 2005

Cite this

@article{9bd01b67faf2453fb6003454950011b7,

title = "Pharmaceutical development of a parenteral lyophilised formulation of the investigational anticancer agent ES-285.HCI",

author = "{den Brok}, M.W.J. and B. Nuijen and D.M. Meijer and E. Millan and C. Manada and J.H. Beijnen",

year = "2005",

language = "Undefined/Unknown",

volume = "59",

pages = "246--257",

journal = "PDA Journal of Pharmaceutical Science and Technology",

issn = "1079-7440",

publisher = "Parenteral Drug Association Inc.",

number = "4",

}

TY - JOUR

T1 - Pharmaceutical development of a parenteral lyophilised formulation of the investigational anticancer agent ES-285.HCI

AU - den Brok, M.W.J.

AU - Nuijen, B.

AU - Meijer, D.M.

AU - Millan, E.

AU - Manada, C.

AU - Beijnen, J.H.

PY - 2005

Y1 - 2005

M3 - Article

SN - 1079-7440

VL - 59

SP - 246

EP - 257

JO - PDA Journal of Pharmaceutical Science and Technology

JF - PDA Journal of Pharmaceutical Science and Technology

IS - 4

ER -